173 related articles for article (PubMed ID: 3346407)
41. Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy.
Crowson AN; Magro CM
Hum Pathol; 1997 Jan; 28(1):67-73. PubMed ID: 9013834
[TBL] [Abstract][Full Text] [Related]
42. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases.
Callen JP; Hughes AP; Kulp-Shorten C
Arch Dermatol; 2001 Sep; 137(9):1196-8. PubMed ID: 11559217
[TBL] [Abstract][Full Text] [Related]
43. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
Wee JS; Natkunarajah J; Marsden RA
Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
[No Abstract] [Full Text] [Related]
44. Norfloxacin-induced subacute cutaneous lupus with erythema multiforme-like lesions: the enigma of the Rowell syndrome.
Baroni A; Piccolo V; Russo T; Cozzolino D; Mascolo M; Chessa MA
J Dtsch Dermatol Ges; 2014 Nov; 12(11):1039-42. PubMed ID: 25382568
[No Abstract] [Full Text] [Related]
45. A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea.
Yanes DA; Mosser-Goldfarb JL
Pediatr Dermatol; 2017 Jan; 34(1):e30-e31. PubMed ID: 27813209
[TBL] [Abstract][Full Text] [Related]
46. Drug-Induced Subacute Cutaneous Lupus Erythematosus in a Patient Receiving Therapy for Chronic Hepatitis C.
Reyes HA; Cativo EH; Sy AM
Am J Ther; 2016; 23(6):e1965-e1967. PubMed ID: 26539906
[TBL] [Abstract][Full Text] [Related]
47. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
Toms-Whittle LM; John LH; Buckley DA
Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
[TBL] [Abstract][Full Text] [Related]
48. De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation.
Bui AN; Hirner J; Singer SB; Eberly-Puleo A; Larocca C; Lian CG; LeBoeuf NR
Clin Exp Dermatol; 2021 Mar; 46(2):328-337. PubMed ID: 32939795
[TBL] [Abstract][Full Text] [Related]
49. [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
Gantzer A; Regnier S; Cosnes A; Ortonne N; Wolkenstein P; Bagot M; Duong TA
Ann Dermatol Venereol; 2011 May; 138(5):409-17. PubMed ID: 21570567
[TBL] [Abstract][Full Text] [Related]
50. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
[TBL] [Abstract][Full Text] [Related]
51. A study of plasma sodium levels in elderly people taking amiloride or triamterene in combination with hydrochlorothiazide.
Fidler HM; Goldman J; Bielawska CA; Rai GS; Hoffbrand BI
Postgrad Med J; 1993 Oct; 69(816):797-9. PubMed ID: 8290411
[TBL] [Abstract][Full Text] [Related]
52. Propranolol ... not guilty.
Packard RC
Headache; 1987 Nov; 27(10):587. PubMed ID: 3692823
[No Abstract] [Full Text] [Related]
53. Docetaxel-induced relapse of subacute cutaneous lupus erythematosus and chilblain lupus.
Lebeau S; També S; Sallam MA; Alhowaish A; Tschanz C; Masouyé I; Borradori L
J Dtsch Dermatol Ges; 2013 Sep; 11(9):871-4. PubMed ID: 23848065
[No Abstract] [Full Text] [Related]
54. Subacute cutaneous lupus erythematosus: is clopidogrel a trigger?
Hewitt C; Carton J; Wakelin S
Clin Exp Dermatol; 2018 Jul; 43(5):600-601. PubMed ID: 29327459
[No Abstract] [Full Text] [Related]
55. Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
Callen JP
JAMA Dermatol; 2013 Sep; 149(9):1075-6. PubMed ID: 23842706
[No Abstract] [Full Text] [Related]
56. Imiquimod-induced subacute cutaneous lupus erythematosus-like changes.
Maguiness SM; Farsani TT; Zedek DC; Berger TG
Cutis; 2015 Jun; 95(6):349-51. PubMed ID: 26125212
[TBL] [Abstract][Full Text] [Related]
57. Subacute cutaneous lupus erythematosus triggered by an antiviral treatment combination for hepatitis C virus infection.
Prenner A; Blum R; Beltraminelli H; Stirnimann G; Borradori L
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):e129-e131. PubMed ID: 30394571
[No Abstract] [Full Text] [Related]
58. A systematic review of drug-induced subacute cutaneous lupus erythematosus.
Lowe GC; Henderson CL; Grau RH; Hansen CB; Sontheimer RD
Br J Dermatol; 2011 Mar; 164(3):465-72. PubMed ID: 21039412
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous lupus erythematosus induced by drugs - novel insights.
Borucki R; Werth VP
Expert Rev Clin Pharmacol; 2020 Jan; 13(1):35-42. PubMed ID: 31774327
[No Abstract] [Full Text] [Related]
60. Pseudoporphyria due to dyazide in a patient with vitiligo.
Motley RJ
BMJ; 1990 Jun; 300(6737):1468. PubMed ID: 2379016
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
